RxDoctor Payments Data

Sean Maynard, PA

Medical · Campbellsville, KYNPI 1962494716

Payments from drug & device makers

$453in general payments, 2019–2025

Across 31 payments — averaging $14.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$86
  • Kowa Pharmaceuticals America, Inc.$45
  • Sanofi-aventis U.S. LLC$40
  • Novartis$36
  • Bayer$35
  • AbbVie$33
  • plus $178 from 8 others

What the payments were for

  • Food & beverage$453100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$453 in reported general payments places this provider in the 40th percentile of 222 medical providers in Kentucky.

See all medical providers in Kentucky

Medicare billing

Part B allowed, 2024
$76,088
Medicare patients
311
Services billed
1,116

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban139$103,744
OzempicSemaglutide84$81,871
FarxigaDapagliflozin Propanediol79$69,617
JanuviaSitagliptin Phosphate62$49,355
XareltoRivaroxaban44$42,037
JardianceEmpagliflozin54$41,725
LinzessLinaclotide64$41,353
MounjaroTirzepatide27$28,698
RexultiBrexpiprazole21$27,791
TrulicityDulaglutide17$27,163
Lantus SolostarInsulin Glargine,hum.Rec.Anlog164$26,371
Tresiba Flextouch U-100Insulin Degludec20$19,261
Breo ElliptaFluticasone/Vilanterol35$17,747
Spiriva RespimatTiotropium Bromide28$17,423
JanumetSitagliptin Phos/Metformin Hcl24$13,526

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$13$103,744139 claims
Novo NordiskOzempic$26$81,87184 claims
MerckJanuvia, Janumet$15$62,88186 claims
Boehringer IngelheimJardiance, Spiriva Respimat$27$59,14882 claims
Lilly USA, LLCMounjaro, Trulicity, Humulin 70-30$86$59,01956 claims
AbbVieLinzess, Fetzima$33$47,21776 claims
Johnson & JohnsonXarelto$15$42,03744 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 222 medical providers in Kentucky.

Other medical in Campbellsville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →